Curcumin: An Insight into Molecular Pathways Involved in Anticancer Activity

(E-pub Ahead of Print)

Author(s): Priyanka Joshi, Sushil Joshi, Deepak Semwal, Akansha Bisht, Sarvesh Paliwal, Jaya Dwivedi, Swapnil Sharma*

Journal Name: Mini-Reviews in Medicinal Chemistry

Become EABM
Become Reviewer
Call for Editor


Curcuma longa has been mentioned in Indian system of medicine for the management of wide range of diseases. C. longa and its metabolites like curcumin, ar-turmerone, methyl-curcumin, demethoxy-curcumin, bisdemethoxy-curcumin have also been reported beneficial in various types of cancer. Curcumin elicits anticancer properties chiefly by triggering apoptotic pathways in cancer cells. The properties are facilitated through diverse signaling pathways viz. pathways mediated by NF-kB, WNT/β-catenin pathway COX-2, LOX, STAT3, prostaglandin E2, phosphorylase kinase, VEGF, AKT, AP1, STAT3, PI3K, Akt, mTOR, ERK5, AP-1, TGF-b, PPARc, EBPa, NLRP3 inflammasome, p38MAPK, Nrf2, Notch-1, AMPK, TLR-4 etc. Present article highlights curcumin biosynthesis, phytochemistry and diverse molecular pathways involved to regulate several types of secondary messengers to exhibit anticancer activity in almost all the forms of cancer.

Keywords: Curcumin, Cancer, Phytochemistry, Molecular pathways, Apoptosis, anticancer activity

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1389557521666210122153823
Price: $95

Article Metrics

PDF: 2